Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;154(2):267-276.
doi: 10.1053/j.gastro.2017.07.045. Epub 2017 Aug 3.

Presentation and Epidemiology of Gastroesophageal Reflux Disease

Affiliations
Review

Presentation and Epidemiology of Gastroesophageal Reflux Disease

Joel E Richter et al. Gastroenterology. 2018 Jan.

Abstract

Gastroesophageal reflux disease (GERD) is the most prevalent gastrointestinal disorder in the United States, and leads to substantial morbidity, though associated mortality is rare. The prevalence of GERD symptoms appeared to increase until 1999. Risk factors for complications of GERD include advanced age, male sex, white race, abdominal obesity, and tobacco use. Most patients with GERD present with heartburn and effortless regurgitation. Coexistent dysphagia is considered an alarm symptom, prompting evaluation. There is substantial overlap between symptoms of GERD and those of eosinophilic esophagitis, functional dyspepsia, and gastroparesis, posing a challenge for patient management.

Keywords: Barrett’s Esophagus; Erosive Esophagitis; Esophageal Stricture.

PubMed Disclaimer

Conflict of interest statement

JHR has no other potential conflicts of interest.

Figures

Figure 1
Figure 1. Prevalence of weekly gastroesophageal reflux symptoms worldwide, based on symptoms at a frequency of once a week or more
(Adapted from Eusebi, et al. Gut. 2017. doi: 10.1136/gutjnl-2016-313589)(34)
Figure 2
Figure 2. Age distribution of GERD-related US hospitalization discharge diagnoses
Upper graphs: age fractions expressed as percent of all patients with a given diagnosis. Lower left graph: age-specific rates of first-listed adenocarcinoma per 100 000, reflux esophagitis per 100 000, esophageal reflux per 10 000, Barrett’s esophagus per 100 000, hiatal hernia per 10 000, and esophageal stricture per 10 000 US population. Lower right graph: age-specific rates of all-listed adenocarcinoma per 100 000, reflux esophagitis per 10 000, esophageal reflux per 10 000, Barrett’s esophagus 10 000, hiatal hernia per 1000, and esophageal stricture per 10 000 US population. (From Thukkani N. & Sonnenberg A., Alimentary Pharmacology and Therapeutics. 2010;31(8):852–61).(36)

References

    1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus. Am J Gastroenterol. 2006;101(8):1900–20. - PubMed
    1. Peery AF, Dellon ES, Lund J, et al. Burden of Gastrointestinal Disease in the United States: 2012 Update. Gastroenterology. 2012;143(5):1179–87.e3. - PMC - PubMed
    1. Johnson DA, Orr WC, Crawley JA, et al. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: A randomized, placebo-controlled trial. Am J Gastroenterol. 2005;100:1914–22. - PubMed
    1. Kessing BF, Bredenoord AJ, Saleh CM, Smout AJPM. Effects of anxiety and depression in patients with gastroesophageal reflux disease. Clin Gsatroenterol and Hepatology. 2015;13:1089–95. - PubMed
    1. Kahrilas PJ, Jonsson A, Denison H, et al. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy. Gut. 2014;63:720–726. - PMC - PubMed

Publication types

MeSH terms